Oncologic drug development needs to place a greater focus on the patient, according to a commentary in the current issue of the New England Journal of Medicine. Even though the US Food and Drug ...
In a Q&A, an FDA spokesperson discusses efforts to reduce misinformation about biosimilars through education, the agency’s collaboration with global regulators to streamline development, and its work ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
FORT DETRICK, Md. – As drug developers rely increasingly on artificial intelligence to assist with the discovery, testing and manufacture of new medicines, researchers at the Defense Health Agency ...
Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and ...
Yoo Chang-ho, head of strategy at SK Biopharmaceuticals, left, and Bae Min-seok, CEO of PhnyX Lab, pose for a commemorative photo marking the signing of a memorandum of understanding on AI-based drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback